RxDoctor Payments Data

Ashley Sharp, MD

Anesthesiology · Washington, DCNPI 1427098367

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Merck at 56.3% of the total. Reporting peaked in 2019 at $170 and has fallen 52.9% since, to $80 in 2025. Among anesthesiology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$833in general payments, 2019–2025

Across 41 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$469
  • Avanos Medical$104
  • Eagle Pharmaceuticals, Inc.$84
  • Mallinckrodt Enterprises LLC$63
  • Mallinckrodt Hospital Products Inc.$31
  • BD$25
  • plus $58 from 3 others

What the payments were for

  • Food & beverage$833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$833 in reported general payments places this provider in the 90th percentile of 253 anesthesiology providers in District of Columbia.

See all anesthesiology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$51,059
Medicare patients
343
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →